InspireMD (NSPR) names Michael Lawless CFO

Go back to InspireMD (NSPR) names Michael Lawless CFO

InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer

June 3, 2025 4:05 PM UTC

Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

MIAMI, June 03, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced the appointment of Michael Lawless, an industry veteran, as Chief Financial Officer, effective on or prior to June 30, 2025 (the Effective Date). On the Effective Date, Mr. Lawless will succeed Craig Shore, who has served as Chief Financial Officer of InspireMD for nearly 15 years.

Mr. Lawless is an experienced public company CFO... More